Panacea Biotec's Oncology Parenteral Formulation Facility at Baddi,
Himachal Pradesh, India, received United States Food & Drug Administration (USFDA) approval
for manufacture and supply of Azacitidine Injection, 100 mg/vial, for the US market.
Panacea Biotec's state-of-the-art pharmaceutical formulation facility at Baddi is already approved by National Regulatory Authority (NRA) of India and USFDA for other oral solids and injectable products.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
